PremiumRatingsU.S. Physical Therapy: Strong Financials and Strategic Growth Drive Buy Rating U.S. Physical Therapy Reports Strong 2024 Results U.S. Physical Therapy Reports Strong Growth Amid Challenges PremiumPre-EarningsUSPH Earnings this Week: How Will it Perform? U.S. Physical Therapy upgraded to Buy from Neutral at BofA U.S. Physical Therapy initiated with an Outperform at JMP Securities PremiumCompany AnnouncementsU.S. Physical Therapy Reports Strong Q3 2024 Growth U.S. Physical Therapy reports Q3 adjusted EPS 55c, consensus 68c USPH Earnings this Week: How Will it Perform?